MyFinsight
Home
Blog
About
Contact
Net loss
attributable to common...
-$2,120,644
Dividend on preferred
stock
-$54,192
Net loss
-$2,174,836
Revenues
$353,375
Operating loss
-$1,443,356
Total other (expense)
income
-$731,480
Gross profit
$62,884
Interest income
$6,653
Cost of revenues
$290,491
Total operating
expenses
$1,506,240
Loss on issuance of
convertible note
-$322,359
Interest expense
$267,008
Loss on change in fair
value of warrant...
-$148,766
Sales, general and
administrative
$1,352,758
Research and development
$153,482
Back
Back
Income Statement
source: myfinsight.com
20 20 Biolabs, Inc. (AIDX)
20 20 Biolabs, Inc. (AIDX)